Lofty expectations for US corporate profits mean that the flood of earnings reports due in the coming fortnight will play a particularly important role in setting the direction for Wall Street stocks, ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

SLB helped lead the market after the provider of services to oilfields delivered bigger profit and revenue for the end of ...

Raising the threshold of eligibility for schools to receive the Community Eligibility Provision could save the government $3 ...

U.S. stocks dipped on Thursday as a jump in the prior session cooled, while investors eyed the most recent corporate earnings ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/98.Bghnd5-7.js ...

Wall Street paused, with stocks ending little changed. Strong bank earnings keep rolling in and Trump's Treasury pick fields ...

Global shares mostly rose Thursday, following a rally on Wall Street driven by encouraging update on U.S. inflation. France's ...

Overall, analysts tracked by FactSet expect UnitedHealth to post $101.6 billion in revenue, up from $94.4 billion a year prior. Analysts also model $6.73 in adjusted earnings per share, up from $6.16 ...

Asian shares mostly rose Thursday, following a rally on Wall Street driven by encouraging update on U.S. inflation.

After a prolonged period of trading in the green the major cryptocurrencies are starting to retrace with some recording ...